[PHARMA] QoQ Cumulative Quarter Result on 30-Jun-2010 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
11-Aug-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
30-Jun-2010 [#2]
Profit Trend
QoQ- 158.45%
YoY- -25.34%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Revenue 385,328 1,378,348 1,002,232 667,895 317,560 1,300,796 976,890 -46.24%
PBT 21,792 45,462 48,163 32,758 12,431 81,436 53,948 -45.38%
Tax -6,193 -15,152 -15,901 -8,931 -3,122 -19,709 -14,337 -42.88%
NP 15,599 30,310 32,262 23,827 9,309 61,727 39,611 -46.30%
-
NP to SH 15,484 30,384 32,640 24,054 9,307 60,191 38,279 -45.33%
-
Tax Rate 28.42% 33.33% 33.01% 27.26% 25.11% 24.20% 26.58% -
Total Cost 369,729 1,348,038 969,970 644,068 308,251 1,239,069 937,279 -46.24%
-
Net Worth 437,661 421,524 424,715 417,306 439,675 431,158 407,610 4.86%
Dividend
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Div - 10,698 50,281 50,290 - 39,585 28,885 -
Div Payout % - 35.21% 154.05% 209.07% - 65.77% 75.46% -
Equity
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Net Worth 437,661 421,524 424,715 417,306 439,675 431,158 407,610 4.86%
NOSH 107,007 106,985 106,981 107,001 106,977 106,987 106,984 0.01%
Ratio Analysis
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
NP Margin 4.05% 2.20% 3.22% 3.57% 2.93% 4.75% 4.05% -
ROE 3.54% 7.21% 7.69% 5.76% 2.12% 13.96% 9.39% -
Per Share
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
RPS 360.09 1,288.35 936.83 624.19 296.85 1,215.84 913.11 -46.25%
EPS 14.47 28.40 30.51 22.48 8.70 56.26 35.78 -45.34%
DPS 0.00 10.00 47.00 47.00 0.00 37.00 27.00 -
NAPS 4.09 3.94 3.97 3.90 4.11 4.03 3.81 4.84%
Adjusted Per Share Value based on latest NOSH - 106,939
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
RPS 26.74 95.64 69.54 46.34 22.03 90.26 67.78 -46.23%
EPS 1.07 2.11 2.26 1.67 0.65 4.18 2.66 -45.53%
DPS 0.00 0.74 3.49 3.49 0.00 2.75 2.00 -
NAPS 0.3037 0.2925 0.2947 0.2895 0.3051 0.2992 0.2828 4.87%
Price Multiplier on Financial Quarter End Date
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Date 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 -
Price 5.73 5.31 4.98 4.98 4.27 4.00 4.09 -
P/RPS 1.59 0.41 0.53 0.80 1.44 0.33 0.45 132.16%
P/EPS 39.60 18.70 16.32 22.15 49.08 7.11 11.43 129.13%
EY 2.53 5.35 6.13 4.51 2.04 14.07 8.75 -56.30%
DY 0.00 1.88 9.44 9.44 0.00 9.25 6.60 -
P/NAPS 1.40 1.35 1.25 1.28 1.04 0.99 1.07 19.64%
Price Multiplier on Announcement Date
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Date 13/05/11 25/02/11 04/11/10 11/08/10 26/05/10 19/02/10 13/11/09 -
Price 5.05 5.35 4.92 4.95 4.71 4.05 3.93 -
P/RPS 1.40 0.42 0.53 0.79 1.59 0.33 0.43 119.82%
P/EPS 34.90 18.84 16.13 22.02 54.14 7.20 10.98 116.33%
EY 2.87 5.31 6.20 4.54 1.85 13.89 9.10 -53.69%
DY 0.00 1.87 9.55 9.49 0.00 9.14 6.87 -
P/NAPS 1.23 1.36 1.24 1.27 1.15 1.00 1.03 12.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment